Business/Brand

Business Domain Vision 2030

Diagram of domains addressed in Business Domain Vision 2030

Eye Care Business

Eye Care Business

We tackle social issues with technology and quality, and provide comprehensive support for eye health.

As aging populations and rising medical costs become social issues, eye care that contributes to maintaining visual function is essential for realizing people's well-being and extending healthy lifespans. Since our founding, we have positioned contributing to people's well-being through eye health as one of our core missions.
Leveraging the technological capabilities and brand power we have cultivated over many years, we provide customers with self-care products that address the diverse eye problems that arise from eye fatigue and the spread of digital devices. We also aim to solve social issues through the eye health of people around the world by expanding into global markets, including Asia and Europe, as well as Japan.

Skincare Business

Skincare Business

We provide high-performance skincare based on science to cater to each and every customer, both in Japan and overseas.

Based on scientific knowledge in the skin field, we provide highly functional skin care products through evidence-based research and development that pursues safety, effectiveness, and mechanisms.We create unique value through Regenerative medicine research and the application of core technologies that we have accumulated over many years, and in recent years have made a full-scale entry into Hair Care Business, strengthening our brand power both domestically and internationally.
Furthermore, we are leveraging our technological capabilities to promote research and development across pharmaceuticals, quasi-drugs, and cosmetics, and continue to venture into new fields centered on our global brands. As a company that generates innovation through skin science and addresses skin and hair concerns around the world, we aim to achieve sustainable growth and value creation.

Major Group subsidiaries involved

  • Domestic

    Amato Pharmaceutical Products, Ltd.
  • abroad

    Mentholatum® Company
  • Hydrox Laboratories, Inc.
  • DAX Cosmetics Sp. z o.o.

Oral Medicine / Health Food Business

Oral Medicine / Health Food Business

"The source of all diseases is the stomach." Based on this belief, which has remained unchanged since our founding, we continue to take on the challenge of preventing illness by utilizing pharmaceuticals and food products.

Food is playing an increasingly important role in maintaining daily health and preventing disease. In order to meet diverse needs, we are focusing on developing products that are both safe and unique.
By bringing together the technology, know-how, and sales channels of our group companies and partner companies, we deliver highly reliable functional foods and oral medications, covering everything from maintaining health and preventing illness to treating minor illnesses and prognosis, delivering health from the inside out.

Major Group subsidiaries involved

  • Domestic

    Qualitech Pharma Co., Ltd.
  • Mayado Pharmaceutical Co., Ltd.
  • MG Pharma Inc.
  • Amato Pharmaceutical Products, Ltd.
  • Hokushin Foods Co., Ltd.
  • Yaeyama Farm Co., Ltd.(Specific agricultural production company)
  • ROHTO RECIPE
  • Hajimariya
  • abroad

    Eu Yan Sang International Ltd

Medical business

Medical business

We provide innovative and multifaceted solutions in Professional care field, with chemical, bio and cell technologies at our core.

As social issues in the medical field become more diverse and complex, such as the aging population, the existence of unmet medical needs, responding to technological innovation and ensuring safety, we continue to take on challenges in Professional care field from various angles, including Ophthalmology area, Regenerative medicine, contract development and manufacturing organization (CDMO), and medical device development. As the company boasts the top share in the domestic OTC eye care category, we are making wide-ranging contributions to the field of Ophthalmology area through the development of ophthalmic drugs and ophthalmic medical devices, leveraging our knowledge. We also pursue the advanced possibilities of Regenerative medicine Regenerative medicine, aiming to implement it in society, such as by contributing to unmet medical needs that are difficult to solve.
Furthermore, backed by the research and development capabilities and high-quality production capabilities we have cultivated over many years, we will contribute to society through our CDMO business, contributing not only to the growth of Medical business but also to the advancement of medicine.

Major Group subsidiaries involved

  • Domestic

    ROHTO NITTEN Co., Ltd.
  • Qualitech Pharma Co., Ltd.
  • Amato Pharmaceutical Products, Ltd.
  • Interstem Co., Ltd.
  • Rohtocell Factory Tokyo Co., Ltd.
  • abroad

    Eu Yan Sang International Ltd
  • Sigmapharm Arzneimittel GmbH
  • Ophthalmos S.A.

Other Businesses

Major Group subsidiaries involved

  • abroad

    Sigmapharm Arzneimittel GmbH